Skip to Main Content

Clinical & Payment Policies

To easily search for a policy, use the Ctrl+F (Command+F on Mac) function on your keyboard to search by keyword, policy number, or effective date.

All policies found in the Arkansas Total Care Clinical Policy Manual apply to Arkansas Total Care members. Policies in the Arkansas Total Care Clinical Policy Manual may have an “Arkansas Total Care” or a “Centene” heading. Arkansas Total Care uses InterQual® criteria for services for which an Arkansas Total Care clinical policy does not exist. InterQual is a nationally recognized, evidence-based decision support tool. You may access the InterQual SmartSheets™ for adult and pediatric procedures, durable medical equipment (DME), and imaging procedures by logging in to our Secure Provider Portal or calling Arkansas Total Care at 1-866-282-6280 (TTY: 711).

Arkansas Total Care may use a vendor for the utilization management of certain services. In such cases, the vendor’s guidelines may also be used to support medical necessity and other coverage decisions. Other non-clinical policies, such as payment policies, or contract terms may also be used to determine if a service that is not addressed in the Clinical Policy Manual or InterQual criteria is payable by Arkansas Total Care.

Arkansas Total Care has partnered with Evolent for prior authorization requests for the following services:

  • Spinal Epidural Injections
    • Paravertebral Facet Joint Injections or Blocks
      • Paravertebral Facet Joint Denervation (Radiofrequency Neurolysis)
        • Sacroiliac Joint Injections

        Clinical Policies for these procedures can be found at the http://www.radmd.com/

        Clinical Policies for CT/CTA/CCTA, MRI, MRA, and Pet scans can also be found at the Evolent Website http://www.radmd.com/

        Clinical policies for musculoskeletal procedures can be found on the Turning point website at http://www.myturningpoint-healthcare.com/

        Drug policies and criteria listed under this section are only applicable to products paid under the medical benefit. Please see “Arkansas Total Care Pharmacy Policies” for prior authorization criteria on drugs paid under the pharmacy benefit.

        Policy TitlePolicy NumberEffective Date
        Abatacept (Orencia) (PDF)CP.PHAR.241September 1, 2024
        AbobotulinumtoxinA (Dysport) (PDF)CP.PHAR.230June 1, 2024
        Acupuncture (PDF)CP.MP.92August 1, 2024
        Ado-Trastuzumab (Kadcyla) (PDF)CP.PHAR.229June 1, 2024
        Aducanumab (Aduhelm) (PDF)CP.PHAR.468June 1, 2024
        Afamelanotide (Scenesse) (PDF)CP.PHAR.444February 1, 2024
        Aflibercept (Eylea) (PDF)CP.PHAR.184November 1, 2024
        Agalsidase beta (Fabrazyme) (PDF)CP.PHAR.158July 1, 2024
        Air Ambulance (PDF)CP.MP.175July 1, 2024
        Alemtuzumab (Lemtrada) (PDF)CP.PHAR.243June 1, 2024
        Alglucosidase (Lumizyme) (PDF)CP.PHAR.160July 1, 2024
        Allogeneic cultured keratinocytes and dermal fibroblasts (StrataGraft)(PDF)CP.PHAR.562February 1, 2024
        Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (PDF)CP.MP.108December 1, 2023
        Allogenic processed thymus tissue-agdc (Rethymic) (PDF)CP.PHAR.563February 1, 2024
        Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF)CP.PHAR.94February 1, 2024
        Amisulpride (Barhemsys) (PDF)CP.PMN.236October 1, 2024
        Amivantamab-vmjw (Rybrevant) (PDF)CP.PHAR.544Janurary 1, 2025
        Anifrolumab-fnia (Saphnelo) (PDF)CP.PHAR.551March 1, 2025
        Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF)CP.PHAR.217February 1, 2024
        Antithrombin III (ATryn, Thrombate III) (PDF)CP.PHAR.564February 1, 2024
        Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF)CP.PHAR.506Janurary 1, 2025
        Adzynma (ADAMTS13, recombinant-krhn) (PDF) CP.PHAR.635 August 1, 2024
        Applied Behavioral Analysis Documentation Requirements (PDF)CP.BH.105May 1, 2025
        Aprepitant (Aponvie, Cinvanti, Emend), (PDF)CP.PMN.19September 1, 2024
        Articular Cartilage Defect Repairs (PDF)CP.MP.26April 1, 2024
        Asfotase Alfa (Strensiq) (PDF)CP.PHAR.328 December 1, 2022
        Assistive Reproductive Technology (PDF)CP.MP.55 March 1, 2024
        Atezolizumab (Tecentriq) (PDF)CP.PHAR.235April 1, 2024
        Atidarsagene autotemcel (Lenmeldy) (PDF)CP.PHAR.602September 1, 2024
        Avacincaptad pegol (Izervay) (PDF)CP.PHAR.641March 1, 2025
        Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF)CP.PHAR.521July 1, 2024
        Avelumab (Bavencio) (PDF)CP.PHAR.333February 1, 2024
        Axatilimab-csfr (Niktimvo) (PDF)CP.PHAR.691January 1, 2024
        Axicabtagene Ciloleucel (Yescarta®) (PDF)CP.PHAR.362February 1, 2024
        Azacitidine (Vidaza) (PDF)CP.PHAR.387March 1, 2025
        Baclofen (Gablofen, Lioresal, Lyvispah, Ozobax) (PDF)CP.PHAR.149Janurary 1, 2025
        Bamlanivimab-etesevimab (LY-CoV555-LY-CoV016) (PDF)CP.PHAR.532July 1, 2023
        Bariatric Surgery (PDF)CP.MP.37August 1, 2024
        Behavioral Health Treatment Documentation Requirements (PDF)CP.BH.500July 1, 2024
        Belantamab mafodotin (Blenrep) (PDF)CP.PHAR.469June 1, 2024
        Belatacept (Nulojix) (PDF)CP.PHAR.201Janurary 1, 2025
        Belimumab (Benlysta) (PDF)CP.PHAR.88 October 1, 2024
        Belinostat (Beleodaq) (PDF)CP.PHAR.311March 1, 2025
        Bendamustine (Bendeka, Treanda) (PDF)CP.PHAR.307March 1, 2025
        Benralizumab (Fasenra) (PDF)CP.PHAR.373Janurary 1, 2025
        Beremagene Geperpavec (Vyjuvek) (PDF) CP.PHAR.592 September 1, 2024
        Betibeglogene autotemcel (PDF)CP.PHAR.545 October 1, 2024
        Bevacizumab (Avastin, Mvasi, Zirabev) (PDF)CP.PHAR.93March 1, 2025
        Bezlotoxumab (Zinplava) (PDF)CP.PHAR.300February 1, 2024
        Bimatoprost Implant (Durysta)(PDF)CP.PHAR.486June 1, 2024
        Biofeedback (PDF)CP.MP.168January 1, 2024
        Biofeedback for Behavioral Health Disorders (PDF)CP.BH.300May 1, 2023
        Blinatumomab (Blincyto) (PDF)CP.PHAR.312November 1, 2024
        Bone-Anchored Hearing Aids (PDF)AR.CP.MP.93August 1, 2023
        Bortezomib (Velcade) (PDF)CP.PHAR.410February 1, 2024
        Bremelanotide (Vyleesi) (PDF)CP.PHAR.434 February 1, 2023
        Brentuximab Vedotin (Adcetris) (PDF)CP.PHAR.303October 1, 2024
        Brexanolone (Zulresso) (PDF)CP.PHAR.417June 1, 2024
        Brexucabtagene Autoleucel (Tecartus) (PDF)CP.PHAR.472April 1, 2024
        Brivaracetam (Briviact) (PDF)CP.PMN.297Janurary 1, 2025
        Brolucizumab-dbll (Beovu) (PDF)CP.PHAR.445 February 1, 2024
        Burn Surgery (PDF)CP.MP.186April 1, 2024
        Buprenorphine implant (Probuphine) (PDF)CP.PHAR.289August 1, 2024
        C1 Esterase Inhibitors (Berinert Cinryze Haegarda Ruconest) (PDF)CP.PHAR.202September 1, 2024
        Cabotegravir, Cabotegravir-Rilpivirine (Apretude Cabenuva) (PDF)CP.PHAR.573October 1, 2024
        Cabazitaxel (Jevtana®) (PDF)CP.PHAR.316June 1, 2024
        Canakinumab (Ilaris) (PDF)CP.PHAR.246July 1, 2024
        Caplacizumab-yhdp (Cablivi)CP.PHAR.416 June 1, 2024
        Carbetocin (PDF)CP.PHAR.546Pending FDA Approval
        Carfilzomib (Kyprolis) (PDF)CP.PHAR.309March 1, 2025
        Casimersen (Amondys 45) (PDF)CP.PHAR.470April 1, 2024
        Casirivimab and Imdevimab (REGEN-COV) (PDF)CP.PHAR.520July 1, 2023
        Caudal or Interlaminar Epidural Steroid Injections (PDF)CP.MP.164August 1, 2024
        Cemiplimab-rwlc (Libtayo) (PDF)CP.PHAR.397Janurary 1, 2025
        Cerliponase alfa (Brineura) (PDF)CP.PHAR.338October 1, 2024
        Certolizumab (Cimzia) (PDF)CP.PHAR.247July 1, 2024
        Cetuximab (Erbitux) (PDF)CP.PHAR.317March 1, 2025
        Chloramphenicol (PDF)CP.PHAR.388September 1, 2024
        Ciltacabtagene Autoleucel (Carvykti)(PDF)CP.PHAR.533 Janurary 1, 2025
        Cipaglucosidase alfa-atga--miglustat (Pombiliti-Opfolda) (PDF)CP.PHAR.567May 1, 2024
        Clinical Trials (PDF)CP.MP.94August 1, 2024
        Cochlear Implanted Replacements (PDF)AR.CP.MP.14September 1, 2024
        Collagenase (Xiaflex) (PDF)CP.PHAR.82September 1, 2024
        Concert Genetic Testing: Aortopathies and Connective Tissue Disorders (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Cardiac Disorders (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Dermatologic Conditions (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Eye Disorders (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Gastroenterologic Disorders (non-cancerous) (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: General Approach to Genetic and Molecular Testing (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Hearing Loss (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Hematologic Conditions (non-cancerous) (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Hereditary Cancer Susceptibility (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Kidney Disorders (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Lung Disorders (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Non-Invasive Prenatal Screening (NIPS) (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Pharmacogenetics (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Preimplantation Genetic Testing (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Prenatal and Preconception Carrier Screening (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF)V2.2024September 1, 2024
        Concert Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF)V2.2024September 1, 2024
        Concert Genetics Oncology: Algorithmic Testing (PDF)V2.2024September 1, 2024
        Concert Genetics Oncology: Cancer Screening (PDF)V2.2024September 1, 2024
        Concert Genetics Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (PDF)V2.2024September 1, 2024
        Concert Genetics Oncology: Cytogenetic Testing (PDF)V2.2024September 1, 2024
        Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF)V2.2024September 1, 2024
        Continuous Glucose Monitors (PDF)CP.PMN.214Janurary 1, 2025
        Copanlisib (Aliqopa) (PDF)CP.PHAR.357March 1, 2025
        Corticosteroid Intravitreal Implants (Iluvien, Ozurdex, Retisert, Yutiq) (PDF)CP.PHAR.385November 1, 2024
        Corticotropin (H.P. Acthar, Purified Cortrophin Gel) (PDF)CP.PHAR.168May 1, 2023
        Cosmetic and Reconstructive Procedures (PDF)CP.MP.31October 1, 2024
        Cosyntropin (Cortrosyn) (PDF)CP.PHAR.203February 1, 2024

        Crizanlizumab-tmca (Adakveo) (PDF)

        CP.PHAR.449February 1, 2024
        Cytomegalovirus Immune Globulin (Cytogam) (PDF)CP.PHAR.277September 1, 2024
        Dalteparin (Fragmin) (PDF)CP.PHAR.225March 1, 2022
        Daprodustat (Jesduvroq) (PDF)CP.PHAR.628August 1, 2024
        Daptomycin (Cubicin, Cubicin RF) (PDF)CP.PHAR.351September 1, 2024
        Daratumumab (Darzalex) (PDF)CP.PHAR.310November 1, 2024
        Darbepoetin Alfa (Aranesp) (PDF)CP.PHAR.236August 1, 2024
        Daunorubicin and Cytarabine (Vyxeos) (PDF)CP.PHAR.352Janurary 1, 2025
        DaxibotulinumtoxinA-lanm (Daxxify) (PDF)CP.PHAR.651Janurary 1, 2025
        Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder (PDF)CP.BH.201August 1, 2024
        Deferoxamine (Desferal) (PDF)CP.PHAR.146September 1, 2024
        Degarelix (Firmagon) (PDF)CP.PHAR.170December 1, 2023
        Delafloxacin (Baxdela) (PDF)CP.PMN.115September 1, 2024
        Delandistrogene Moxeparvovec-rokl  (Elevidys) (PDF) CP.PHAR.593 November 1, 2024
        Delandistrogene Moxeparvovec-rokl  (Elevidys) (PDF) CP.PHAR.593 Retire by November 1, 2024
        Denileukin Diftitox-cxdl (Lymphir) (PDF)CP.PHAR.693Janurary 1, 2024
        Denosumab (Prolia, Xgeva) (PDF)CP.PHAR.58November 1, 2024
        Desmopressin Acetate (DDAVP, Stimate, Nocdurna, Noctiva) (PDF)CP.PHAR.214February 1, 2024
        Dexrazoxane (Zinecard, Totect) (PDF)CP.PHAR.418July 1, 2024
        Diaphragmatic/Phrenic Nerve Stimulation (PDF)CP.MP.203September 1, 2024
        Disc Decompression Procedures (PDF)CP.MP.114October 1, 2024
        Discography (PDF)CP.MP.115July 1, 2024
        Donor Lymphocyte Infusion (PDF)CP.MP.101June 1, 2024
        Dostarlimab-gxly (Jemperli) (PDF)CP.PHAR.540November 1, 2024
        Durable Medical Equipment and Orthotics and Prosthetics Guidelines (PDF)CP.MP.107October 1, 2024
        Durvalumab (Imfinzi) (PDF)CP.PHAR.339November 1, 2024
        Ecallantide (Kalbitor) (PDF)CP.PHAR.177September 1, 2024
        Eculizumab (Soliris) (PDF)CP.PHAR.97October 1, 2024
        Edaravone (Radicava) (PDF)CP.PHAR.343June 1, 2024
        Efgartigimod alfa-fcab (Vyvgart) (PDF)
        CP.PHAR.555
        Janurary 1, 2025
        Elapegademase-lvlr (Revcovi) (PDF)CP.PHAR.419June 1, 2024
        Electric Tumor Treating Fields (Optune) (PDF)CP.MP.145January 1, 2024
        Elivaldogene autotemcel  (Skysona) (PDF)CP.PHAR.556Janurary 1, 2025
        Elosulfase Alfa (Vimizim) (PDF)CP.PHAR.162June 1, 2024
        Elotuzumab (Empliciti) (PDF)CP.PHAR.308March 1, 2025
        Elranatamab-bcmm (Elrexfio) (PDF)CP.PHAR.652Janurary 1, 2025
        Emapalumab-lzsg (Gamifant) (PDF)CP.PHAR.402April 1, 2024
        Enfortumab Vedotin-ejfv (Padcev) (PDF)CP.PHAR.455February 1, 2024
        Enfuvirtide (Fuzeon) (PDF)CP.PHAR.41September 1, 2023
        Enoxaparin (Lovenox) (PDF)CP.PHAR.224February 1, 2024
        Epcoritamab-bysp (Epkinly) (PDF)CP.PHAR.634September 1, 2024
        Epoetin Alfa (Epogen® and Procrit) (PDF)CP.PHAR.237August 1, 2024
        Epoprostenol (Flolan, Veletri) (PDF)CP.PHAR.192February 1, 2024
        Eptinezumab-jjmr (Vyepti) (PDF)CP.PHAR.489March 1, 2025
        Eribulin Mesylate (Halaven) (PDF)CP.PHAR.318Janurary 1, 2025
        Erwinia Asparaginase (Erwinaze) (PDF)CP.PHAR.301February 1, 2024
        Etelcalcetide (Parsabiv) (PDF)CP.PHAR.379September 1, 2024
        Eteplirsen  (Exondys 51) (PDF)CP.PHAR.288April 1, 2024
        Etranacogene Dezaparvovec (Hemgenix) (PDF)CP.PHAR.580March 1, 2025
        Evinacumab-dgnb (Evkeeza) (PDF)CP.PHAR.511April 1, 2024
        Exagamglogene Autotemcel (Exa-Cel) (PDF)CP.PHAR.603July 1, 2024
        Experimental Technologies (PDF)CP.MP.36June 1, 2024
        Facet Joint Interventions (PDF)CP.MP.171Janurary 1, 2025
        Facility-based Sleep Studies for Obstructive Sleep Apnea (PDF)CP.MP.248June 1, 2024
        Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF)CP.PHAR.220September 1, 2024
        Factor VIII (Human Recombinant) (PDF)CP.PHAR.215 June 1, 2024
        Factor VIII/von Willebrand Factor Complex (Human - Alphanate®, Humate-P®, Wilate®) (PDF)CP.PHAR.216June 1, 2024
        Factor IX (Human, Recombinant) (PDF)CP.PHAR.218June 1, 2024
        Factor IX Complex, Human (Profilnine) (PDF)CP.PHAR.219June 1, 2024
        Factor XIII, Human (Corifact®) (PDF)CP.PHAR.221February 1, 2024
        Factor XIII A-Subunit, Recombinant (Tretten®)CP.PHAR.222February 1, 2024
        Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (PDF)CP.PHAR.456August 1, 2024
        Faricimab (Vabysmo) (PDF)CP.PHAR.581October 1, 2024
        Fecal Incontinence Treatments (PDF)CP.MP.137August 1, 2024
        Ferric Carboxymaltose (Injectafer) (PDF)CP.PHAR.234September 1, 2024
        Ferric Derisomaltose (Monoferric) (PDF)CP.PHAR.480November 1, 2024
        Ferric Derisomaltose (Monoferric) (PDF)CP.PHAR.480Retire by November 1, 2024
        Ferric Pyrophosphate Citrate (Triferic) (PDF)CP.PHAR.624June 1, 2024
        Ferumoxytol (Feraheme) (PDF)CP.PHAR.165September 1, 2024
        Fertility Preservation (PDF)CP.MP.130March 1, 2024
        Fetal Surgery in Utero for Prenatally Diagnosed Malformations (PDF)CP.MP.129November 1, 2024
        Fibrinogen concentrate (human) (Fibryga, RiaSTAP) (PDF)CP.PHAR.526November 1, 2024
        Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF)CP.PHAR.643Janurary 1, 2025
        Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix) (PDF)CP.PHAR.297Retire by November 1, 2024
        Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix) (PDF)CP.PHAR.297November 1, 2024
        Fondaparinux (Arixtra) (PDF)CP.PHAR.226March 1, 2022
        Fosdenopterin (Nulibry) (PDF)CP.PHAR.471 June 1, 2024
        Fulvestrant (Faslodex Injection) (PDF)CP.PHAR.424October 1, 2023
        Functional MRI (PDF)CP.MP.43April 1, 2024
        Galsulfase (Naglazyme) (PDF)CP.PHAR.161June 1, 2024
        Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (PDF)CP.MP.209August 1, 2023
        Gastric Electrical Stimulation (PDF)CP.MP.40July 1, 2024
        Gemtuzumab (Mylotarg) (PDF)CP.PHAR.358Janurary 1, 2025
        Gender-Affirming Procedures (PDF)CP.MP.95September 1, 2024
        Givosiran (Givlaari) (PDF)CP.PHAR.457April 1, 2024
        Glofitamab-gxbm (Columvi) (PDF) CP.PHAR.636 September 1, 2024
        Golodirsen (Vyondys 53) (PDF)CP.PHAR.453April 1, 2024
        Golimumab (Simponi, Simponi Aria) (PDF)CP.PHAR.253September 1, 2024
        Goserelin Acetate (Zoladex) (PDF)CP.PHAR.171Janurary 1, 2025
        Granisetron (Kytril, Sancuso, Sustol) (PDF)CP.PMN.74Janurary 1, 2025
        Hemin (Panhematin) (PDF)CP.PHAR.181February 1, 2024
        Histrelin (Vantas, Supprelin LA) (PDF)CP.PHAR.172July 1, 2024
        Home and Community Based Services (HCBS) (PDF)AR.CP.BH.503October 1, 2024
        Home Births (PDF)CP.MP.136March 1, 2024
        Home Ventilators (PDF)CP.MP.184October 1, 2024
        Hospice Services (PDF)CP.MP.54November 1, 2024
        Hyaluronate Derivatives (PDF)CP.PHAR.05Janurary 1, 2025
        Hydroxyprogesterone caproate (Makena) (PDF)CP.PHAR.14June 1, 2024
        Hyperhidrosis Treatments (PDF)CP.MP.62June 1, 2024
        ibalizumab-uiyk (Trogarzo) (PDF)CP.PHAR.378August 1, 2024
        Ibandronate Injection (Boniva) (PDF)CP.PHAR.189April 1, 2024
        Idecabtagene vicleucel (Abecma) (PDF)CP.PHAR.481 Janurary 1, 2025
        Idursulfase (Elaprase) (PDF)CP.PHAR.156June 1, 2024
        Iloprost (Ventavis) (PDF)CP.PHAR.193February 1, 2024
        Imetelstat (Rytelo) (PDF)CP.PHAR.690September 1, 2024
        Imiglucerase (Cerezyme) (PDF)CP.PHAR.154June 1, 2024
        Immune Globulins (PDF)CP.PHAR.103Januraray  1, 2025
        Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (PDF)CP.MP.180January 1, 2024
        Implantable Intrathecal or Epidural Pain Pump (PDF)CP.MP.173Janurary 1, 2025
        Implantable Loop Recorder (PDF)CP.MP.243June 1, 2024
        Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF)CP.MP.160June 1, 2024
        Inclisiran (Leqvio) (PDF)CP.PHAR.568April 1, 2024
        IncobotulinumtoxinA (Xeomin) (PDF)CP.PHAR.231October 1, 2024
        Inotersen (Tegsedi) (PDF)CP.PHAR.405 February 1, 2023
        Inebilizumab (PDF)CP.PHAR.458October 1, 2024
        Infertility and Fertility Preservation (PDF)CP.PHAR.131March 1, 2025
        Infliximab (Remicade, Inflectra, Renflexis) (PDF)CP.PHAR.254October 1, 2024
        Inotuzumab Ozogamicin (Besponsa) (PDF)CP.PHAR.359Janurary 1, 2025
        Intensity-Modulated Radiotherapy (PDF)CP.MP.69September 1, 2024
        Interferon Gamma- 1b (Actimmune) (PDF)CP.PHAR.52February 1, 2024
        Intestinal and Multivisceral Transplant (PDF)CP.MP.58July 1, 2023 
        Intradiscal Steroid Injections for Pain Management (PDF)CP.MP.167September 1, 2024
        Iobenguane I-131 (Azedra) (PDF)CP.PHAR.459February 1, 2024
        Ipilimumab (Yervoy) (PDF)CP.PHAR.319June 1, 2024
        Irinotecan Liposome (Onivyde) (PDF)CP.PHAR.304Janurary 1, 2025
        Isatuximab-irfc (Sarclisa)(PDF)CP.PHAR.482June 1, 2024
        Isavuconazonium (Cresemba)CP.PMN.154
        June 1, 2024
        IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (PDF)CP.MP.61October 1, 2024
        Ixekizumab (Taltz) (PDF)CP.PHAR.257June 1, 2023
        Ketamine (Ketalar) (PDF)CP.PMN.296September 1, 2024
        Lanadelumab-fylo (Takhzyro) (PDF)CP.PHAR.396September 1, 2024
        Lanreotide (Somatuline Depot) (PDF)CP.PHAR.391Janurary 1, 2025
        Lantidra (donislecel): Allogenic Pancreatic Islet Cellular Therapy (PDF)CP.MP.250September 1, 2024
        Laronidase (Aldurazyme) (PDF)CP.PHAR.152June 1, 2024
        Lecanemab-irmb (Leqembi) (PDF)CP.PHAR.596March 1, 2025
        Lefamulin (Xenleta) (PDF)CP.PMN.219September 1, 2024
        Letermovir (Prevymis) (PDF)CP.PHAR.367January 1, 2025
        Letermovir (Prevymis) (PDF)CP.PHAR.367Retire by January 1, 2025
        Leucovorin Injection (PDF)CP.PHAR.393Janurary 1, 2025
        Leuprolide Acetate (Lupron, Lupron Depot, Eligard, Lupaneta Pack, Fensolvi) (PDF)CP.PHAR.173Janurary 1, 2025
        Levoleucovorin (Fusilev, Khapzory) (PDF)CP.PHAR.151Janurary 1, 2025
        Lifileucel (Amtagvi) (PDF)CP.PHAR.598Janurary 1, 2025
        Linezolid (Zyvox) (PDF)CP.PMN.27October 1, 2024
        Liposuction for Lipedema (PDF)CP.MP.244July 1, 2024
        Lisocabtagene maraleucel (Breyanzi) (PDF)CP.PHAR.483August 1, 2024
        Loncastuximab tesirine-lpyl (Zynlonta) (PDF)CP.PHAR.539September 1, 2024
        Long Term Care Placement (PDF)CP.MP.71April, 1 2024
        Lovotibeglogene Autotemcel (Lovo-Cel) (PDF)CP.PHAR.627August 1, 2024
        Lumasiran (Oxlumo) (PDF)CP.PHAR.473August 1, 2024
        Lurbinectedin (Zepzelca) (PDF)CP.PHAR.500September 1, 2024
        Luspatercept-aamt (Reblozyl) (PDF)CP.PHAR.450December 1, 2024
        Luspatercept-aamt (Reblozyl) (PDF)CP.PHAR.450Retire by December 1, 2024
        Lutetium Lu 177 Dotatate (Lutathera) (PDF)CP.PHAR.384September 1, 2024
        Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (PDF)CP.PHAR.582June 1, 2024
        Lysis of Epidural Lesions (PDF)CP.MP.116July 1, 2024
        Margetuximab-cmkb (Margenza) (PDF)CP.PHAR.522February 1, 2024
        Mecasermin (Increlex) (PDF)CP.PHAR.150October 1, 2024
        Mechanical Stretching Devices for Joint Stiffness and Contracture (PDF)CP.MP.144December 1, 2024
        Melphalan (Hepzato) (PDF)CP.PHAR.653Janurary 1, 2025
        Melphalan flufenamide (Pepaxto) (PDF)CP.PHAR.535June 1, 2024
        Mepolizumab (Nucala) (PDF)CP.PHAR.200April 1, 2022
        Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex) (PDF)CP.PHAR.134 December 1, 2022
        Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF)CP.PHAR.238 August 1, 2024
        Metreleptin (Myalept) (PDF)CP.PHAR.425September 1, 2024
        Mirikizumab-mrkz (Omvoh) (PDF)CP.PHAR.662August 1, 2024
        Mirvetuximab soravtansine-gynx (Elahere) (PDF)CP.PHAR.617July 1, 2024
        Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF)CP.PHAR.495September 1, 2024
        Mitoxantrone (Novantrone) (PDF)CP.PHAR.258July 1, 2024
        Mogamulizumab-kpkc (Poteligeo) (PDF)CP.PHAR.139March 1, 2025
        Mometasone Furoate (Sinuva) (PDF)CP.PHAR.448September 1, 2024
        Mosunetuzumab-axgb (Lunsumio) (PDF)CP.PHAR.618February 1, 2024
        Motixafortide (Aphexda) (PDF)CP.PHAR.655Janurary 1, 2025
        Moxetumomab Pasudotox-tdfk (Lumoxiti) (PDF)CP.PHAR.398Janurary 1, 2025
        Multiple Sleep Latency Testing (PDF)CP.MP.24July 1, 2024
        Nadofaragene Firadenovec (Instiladrin)(PDF)CP.PHAR.461March 1, 2025
        Natalizumab (Tysabri) (PDF)CP.PHAR.259September 1, 2024
        Naxitamab-gqgk (Danyelza) (PDF)CP.PHAR.523February 1, 2024
        Necitumumab (Portrazza) (PDF)CP.PHAR.320Janurary 1, 2025
        Nedosiran (Rivfloza) (PDF)CP.PHAR.619August 1, 2024
        Nemolizumab-ito (Nemluvio) (PDF)CP.PHAR.703Janurary 1, 2025
        Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (PDF)CP.MP.48August 1, 2024
        Netupitant and Palonosetron (Akynzeo) (PDF)CP.PMN.158September 1, 2024
        Nerve Blocks and Neurolysis for Pain Management (PDF)CP.MP.170Janurary 1, 2025
        Nirsevimab (Beyfortus) 08.07.23 (PDF)CP.PHAR.614September 1, 2024
        Nivolumab (Opdivo) (PDF)CP.PHAR.121  Janurary 1, 2025
        Nivolumab and Relatlimab (Opdualag) (PDF)CP.PHAR.588September 1, 2024
        No Coverage Criteria (PDF)CP.PMN.255Janurary 1, 2025
        Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF)CP.PHAR.684September 1, 2024
        Nonmyeloablative Allogeneic Stem Cell Transplants (PDF)CP.MP.141July 1, 2024
        Nusinersen (Spinraza®) (PDF)CP.PHAR.327February 1, 2024
        Obstetrical Home Care Programs (PDF)CP.MP.91July 1, 2024
        Obinutuzumab (Gazyva) (PDF)CP.PHAR.305Janurary 1, 2025
        Ocrelizumab (Ocrevus) (PDF)CP.PHAR.335June 1, 2024
        Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF)CP.PHAR.40September 1, 2024
        Ofatumumab (Arzerra, Kesimpta) (PDF)CP.PHAR.306June 1, 2024
        Off-Label Use (PDF)CP.PMN.53March 1, 2025
        Olaparib (Lynparza) (PDF)CP.PHAR.360May 1, 2023
        Olipudase alfa-rpcp (Xenpozyme) (PDF)CP.PHAR.586September 1, 2024
        Omadacycline (Nuzyra) (PDF)CP.PMN.188September 1, 2024
        Omalizumab (Xolair) (PDF)CP.PHAR.01August 1, 2024
        Omecetaxine (Synribo) (PDF)CP.PHAR.108June 1, 2024
        Omisirge (omidubicel): Nicotinamide-modified allogeneic hematopoietic progenitor cell therapy (PDF)CP.MP.249August 1, 2024
        OnabotulinumtoxinA (Botox) (PDF)CP.PHAR.232Janurary 1, 2025
        Onasemnogene Abeparvovec (Zolgensma) (PDF)CP.PHAR.421September 1, 2024
        Ophthalmic Riboflavin (Photrexa, Photrexa Viscous)CP.PHAR.536June 1, 2024
        Orthognathic Surgery (PDF)CP.MP.202 October 1, 2024
        Osteogenic Stimulation (PDF)CP.MP.194 September 1, 2024
        Outpatient Cardiac Rehabilitation (PDF)CP.MP.176September 1, 2024
        Outpatient Oxygen Use (PDF)CP.MP.190June 1, 2024
        Paclitaxel protein-bound (Abraxane) (PDF)CP.PHAR.176November 1, 2024
        Panitumumab (Vectibix) (PDF)CP.PHAR.321March 1, 2025
        Panniculectomy (PDF)CP.MP.109October 1, 2024
        Paricalcitol Injection (Zemplar) (PDF)CP.PHAR.270September 1, 2024
        Pasireotide (Signifor, Signifor LAR) (PDF)CP.PHAR.332Janurary 1, 2025
        Patisiran (Onpattro) (PDF)CP.PHAR.395July 1, 2024
        Peanut Allergen Powder-dnfp (Palforzia)(PDF)CP.PMN.220March 1, 2021
        Pediatric Liver Transplant (PDF)CP.MP.120July 1, 2024
        Pediatric Oral Function Therapy (PDF)CP.MP.188July 1, 2024
        Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (PDF)CP.PHAR.353March 1, 2025
        Pegcetacoplan (Empaveli) (PDF)CP.PHAR.524October 1, 2024
        Pegfilgrastim (Neulasta, Fulphila, Udenyca, Ziextenzo) (PDF)CP.PHAR.296October 1, 2024
        Pegloticase (Krystexxa) (PDF)CP.PHAR.115February 1, 2024
        Pegunigalsidase alfa-iwxj (Elfabrio) (PDF)CP.PHAR.512September 1, 2024
        Pegvaliase-pqpz (Palynziq) (PDF)CP.PHAR.140Janurary 1, 2025
        Pegvisomant (Somavert) (PDF)CP.PHAR.389Janurary 1, 2025
        Pembrolizumab (Keytruda®) (PDF)CP.PHAR.322Janurary 1, 2025
        Pemetrexed (Alimta, Pemfexy) (PDF)CP.PHAR.368February 1, 2024
        Percutaneous Left Atrial Appendage Closure for Stroke Prevention (PDF)CP.MP.147July 1, 2024
        Personal Care Services Authorization (PDF)ARTC.UM.19July 1, 2024
        Pertuzumab (Perjeta) (PDF)CP.PHAR.227June 1, 2024
        Pertuzumab-trastuzumab-hyaluronidase-zzxf (Phesgo) (PDF)CP.PHAR.501September 1, 2024
        Physical, Occupational, and Speech Therapy Services (PDF)CP.MP.49August 1, 2024
        Plasminogen (Ryplazim) (PDF)CP.PHAR.513Janurary 1, 2025
        Plerixafor (Mozobil) (PDF)CP.PHAR.323October 1, 2024
        Polatuzumab Vedotin-piiq (Polivy) (PDF)CP.PHAR.433September 1, 2024
        Posterior Tibial Nerve Stimulation for Voiding Dysfunction (PDF)CP.MP.133September 1, 2024
        Pozelimab (REGN3918) (PDF)CP.PHAR.626May 1, 2024
        Prademagene Zamikeracel (EB-101) (PDF)CP.PHAR.609Pending FDA Approval
        Pralatrexate (Folotyn) (PDF)CP.PHAR.313March 1, 2025
        Protein C Concentrate, Human (Ceprotin) PDF)CP.PHAR.330February 1, 2024
        Proton and Neutron Beam Therapies (PDF)CP.MP.70January 1, 2024
        Ramucirumab (Cyramza) (PDF)CP.PHAR.119 February 1, 2024
        Ranibizumab (Byooviz, Lucentis, Susvimo) (PDF)CP.PHAR.186January 1, 2025
        Ranibizumab (Byooviz, Lucentis, Susvimo) (PDF)CP.PHAR.186Retire by January 1, 2025
        Ravulizumab-cwvz (Ultomiris) (PDF)CP.PHAR.415October 1, 2024
        Reduction Mammoplasty and Gynecomastia Surgery (PDF)CP.MP.51November 1, 2024
        Repair of Nasal Valve Compromise (PDF)CP.MP.210July 1, 2024
        Reslizumab (Cinqair) (PDF)CP.PHAR.223February 1, 2024
        Respiratory Syncytial Virus Vaccine (Abrysvo) C (PDF)CP.PHAR.658Janurary 1, 2025
        Retifanlimab-dlwr (Zynyz) (PDF)CP.PHAR.629July 1, 2024
        Rilonacept (Arcalyst) (PDF)CP.PHAR.266July 1, 2024
        RimabotulinumtoxinB (Myobloc) (PDF)CP.PHAR.233June 1, 2024
        Risankizumab-rzaa (Skyrizi) (PDF)CP.PHAR.426September 1, 2024
        Risdiplam (Evrysdi) (PDF)CP.PHAR.477February 1, 2024
        Rituximab (Rituxan), Rituxan/Hyaluronidase (Rituxan Hycela) (PDF)CP.PHAR.260August 1, 2024
        Rolapitant (Varubi) (PDF)CP.PMN.102September 1, 2024
        Romidepsin (Istodax) (PDF)CP.PHAR.314Janurary 1, 2025
        Romiplostim (Nplate®) (PDF)CP.PHAR.179April 1, 2024
        Ropeginterferon alfa-2b-njft (Besremi) (PDF)CP.PHAR.570July 1, 2024
        Rozanolixizumab-noli (Rystiggo) (PDF)CP.PHAR.648March 1, 2025
        Sacituzumab Govitecan-hziy (Trodelvy) (PDF)CP.PHAR.475June 1, 2024
        Sacroiliac Joint Fusion (PDF)CP.MP.126October 1, 2024
        Sacroiliac Joint Interventions for Pain Management (PDF)CP.MP.166September 1, 2024
        Sargramostim (Leukine) (PDF)CP.PHAR.295October 1, 2024
        Satralizumab-mwge (Enspryng) (PDF)CP.PHAR.463October 1, 2024
        Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (PDF)CP.MP.146September 1, 2024
        Sebelipase Alfa (Kanuma) (PDF)CP.PHAR.159June 1, 2024
        Secukinumab (Cosentyx) (PDF)CP.PHAR.261July 1, 2024
        Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy (PDF)CP.MP.174January 1, 2024
        Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (PDF)CP.MP.165September 1, 2024
        Setmelanotide (Imcivree) (PDF)CP.PHAR.491 December 1, 2022
        Sipuleucel-T (Provenge) (PDF)CP.PHAR.120June 1, 2024
        Siltuximab (Sylvant) (PDF) CP.PHAR.329February 1, 2024
        Sirolimus Protein-Bound Particles (Fyarro), topical gel (Hyftor)CP.PHAR.574February 1, 2024
        Skin and Soft Tissue Substitutes for Chronic Wounds (PDF)CP.MP.185August 1, 2024
        Sodium thiosulfate (Pedmark) (PDF)CP.PHAR.610May 1, 2024
        Sotatercept (ACE-011) (PDF)CP.PHAR.657Pending FDA Approval
        Sotrovimab (VIR-7831) (PDF)CP.PHAR.541July 1, 2023
        Spesolimab-sbzo (Spevigo) (PDF)CP.PHAR.606August 1, 2024
        Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (PDF)CP.MP.117October 1, 2024
        Stereotactic Body Radiation Therapy (PDF)CP.MP.22December 1, 2024
        Sutimlimab-jome (Enjaymo) (PDF)CP.PHAR.503June 1, 2024
        Tafasitamab-cxix (Monjuvi) (PDF)CP.PHAR.508March 1, 2025
        Taliglucerase Alfa (Elelyso) (PDF)CP.PHAR.157June 1, 2024
        Talimogene laherparepvec (Imlygic) (PDF)CP.PHAR.542September 1, 2024
        Talquetamab-tgvs (Talvey) (PDF)CP.PHAR.649March 1, 2025
        Tarlatamab-dlle (Imdelltra) (PDF)CP.PHAR.685September 1, 2024
        Tebentafusp-(Kimmtrak) (PDF)CP.PHAR.575 June 1, 2024
        Teclistamab-cqyv (Tecvayli) (PDF)CP.PHAR.611February 1, 2024
        Tedizolid (Sivextro) (PDF)CP.PMN.62September 1, 2024
        Teduglutide (Gattex) (PDF)CP.PHAR.114April 1, 2024
        Temozolomide (Temodar) (PDF)CP.PHAR.77July 1, 2024
        Temsirolimus (Torisel) (PDF)CP.PHAR.324Janurary 1, 2025
        Teplizumab-mzwv (Tzield) (PDF)CP.PHAR.492February 1, 2024 (Previously Pending FDA Approval)
        Teprotumumab (Tepezza) (PDF)CP.PHAR.465February 1, 2024
        Testosterone (Testopel, Jatenzo) (PDF)CP.PHAR.354Janurary 1, 2025
        Tezepelumab (Tezspire) (PDF)CP.PHAR.576 February 1, 2024
        Therapeutic Utilization of Inhaled Nitric Oxide (PDF)CP.MP.87July 1, 2024
        Thyrotropin alfa (Thyrogen) (PDF)CP.PHAR.95September 1, 2024
        Tildrakizumab-asmn (Ilumya)CP.PHAR.386July 1, 2024
        Tisagenlecleucel (Kymriah) (PDF)CP.PHAR.361April 1, 2024
        Tislelizumab-jsgr (Tevimbra) (PDF)CP.PHAR.687November 1, 2024
        Tisotumab Vedotin-tftv (Tivdak) (PDF)CP.PHAR.561 March 1, 2025
        Tixagevimab-Cilgavimab (Evusheld) (PDF)CP.PHAR.571July 1, 2023
        Tobramycin (Bethkis, Kitabis Pak, TOBI, TOBI Podhaler) (PDF)CP.PHAR.211March 1, 2022
        Tocilizumab (Actemra) (PDF)CP.PHAR.263January 1, 2025
        Tocilizumab (Actemra) (PDF)CP.PHAR.263Retire by January 1, 2025
        Tofersen (Qalsody) (PDF)CP.PHAR.591Janurary 1, 2025
        Topotecan (Hycamtin) (PDF)CP.PHAR.64July 1, 2024
        Toripalimab (Loqtorzi) (PDF)CP.PHAR.668September 1, 2024
        Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF)CP.MP.163April 1, 2024
        Trabectedin (Yondelis) (PDF)CP.PHAR.204February 1, 2024
        Tralokinumab-ldrm (Adbry) (PDF)CP.PHAR.577 June 1, 2022
        Transcranial Magnetic Stimulation for Treatment Resistant Major Depression (PDF)CP.BH.200August 1, 2024
        Transplant Service Documentation Requirements (PDF)CP.MP.247April 1, 2024
        Trastuzumab (Herceptin), Trastuzumab-dkst (Ogivri) (PDF)CP.PHAR.228August 1, 2024
        Travoprost (iDose TR) (PDF)CP.PHAR.672August 1, 2024
        Tremelimumab-actl (Imjudo) (PDF)CP.PHAR.612December 1, 2024
        Tremelimumab-actl (Imjudo) (PDF)CP.PHAR.612Retire by December 1, 2024
        Treprostinil (Orenitram, Remodulin, Tyvaso) (PDF)CP.PHAR.199February 1, 2024
        Triamcinolone ER Injection (Zilretta) (PDF)CP.PHAR.371September 1, 2024
        Trigger Point Injections for Pain Management (PDF)CP.MP.169September 1, 2024
        Triptorelin pamoate (Trelstar, Triptodur) (PDF)CP.PHAR.175Janurary 1, 2025
        Ublituximab-xiiy (Briumvi) (PDF)CP.PHAR.621June 1, 2024
        Urinary Incontinence Devices and Treatments (PDF)CP.MP.142January 1, 2024
        Ustekinumab (Stelara) (PDF)CP.PHAR.264Janurary 1, 2025
        Vagus Nerve Stimulation (PDF)CP.MP.12September 1, 2024
        Valoctocogene Roxaparvovec (PDF)CP.PHAR.466April 1, 2024 (Previously Pending FDA Approval)
        Valrubicin (Valstar) (PDF)CP.PHAR.439March 1, 2025
        Vedolizumab (Entyvio) (PDF)CP.PHAR.265August 1, 2024
        Velaglucerase alfa (VPRIV) (PDF)CP.PHAR.163June 1, 2024
        Velmanase Alfa-tycv (Lamzede) (PDF)CP.PHAR.601June 1, 2024
        Ventricular Assist Devices (PDF)CP.MP.46April 1, 2024
        Verteporfin (Visudyne) (PDF)CP.PHAR.187February 1, 2024
        Vestronidase Alfa-vjbk (Mepsevii) (PDF)CP.PHAR.374July 1, 2024
        Viltolarsen (Viltepso) (PDF)CP.PHAR.484April 1, 2024
        Voretigene neparvovec-rzyl (Luxturna) (PDF)CP.PHAR.372February 1, 2024
        Vosoritide (Voxzogo) (PDF)CP.PHAR.525February 1, 2024
        Vutrisiran (Amvuttra) (PDF)CP.PHAR.550 December 1, 2022
        Waiver Environmental Modifications Criteria (PDF)ARTC.CC.25September 1, 2022
        Zavegepant (Zavzpret) (PDF)CP.PHAR.630March 1, 2025
        Ziv-aflibercept (Zaltrap) (PDF)CP.PHAR.325Janurary 1, 2025
        Zoledronic Acid (PDF)CP.PHAR.59February 1, 2024

        Policy TitlePolicy NumberEffective Date
        25-hydroxyvitamin D Testing in Children and Adolescents (PDF)CP.MP.157November 1, 2024
        3-Day Payment Window (PDF)CC.PP.500July 1, 2014
        Add-On Code Billed Without Primary Code (PDF)CC.PP.030October 18, 2016
        Aducanumab (Aduhelm) (PDF)CP.PHAR.468December 1, 2021
        Allergy Testing and Therapy (PDF)CP.MP.100November 1, 2024
        Assistant Surgeon (PDF)CC.PP.029February 7, 2017
        Attention Deficit Hyperactivity Disorder Assessment and Treatment (PDF)CP.BH.124December 1, 2024
        Bevacizumab (PDF)CP.PHAR.93August 1, 2021
        Bilateral Procedures (PDF)CC.PP.037February 7, 2017
        Bronchial Thermoplasty (PDF)CP.MP.110November 1, 2024
        Cardiac Biomarker Testing (PDF)CP.MP.156November 1, 2024
        Cerumen Removal (PDF)CC.PP.008August 12, 2016
        Clean Claims (PDF)CC.PP.021October 18, 2016
        Coding Overview (PDF)CC.PP.011October 18, 2016
        Cosmetic Procedures (PDF)CC.PP.024October 18, 2016
        Digital EEG Spike Analysis (PDF)CP.MP.105November 1, 2024
        Distinct Procedural Modifiers (PDF)CC.PP.020October 18, 2016
        Drugs of Abuse: Definitive Testing (PDF)CP.MP.50November 1, 2024
        Duplicate Primary Code Billing (PDF)CC.PP.044February 7, 2017
        EEG in the Evaluation of Headache (PDF)CP.MP.155November 1, 2024
        E&M Medical Decision-Making (PDF)CC.PP.051July 25, 2017
        EEG in the Evaluation of Headache (PDF)CP.MP.155November 1, 2024
        EM Bundling Edits (PDF)CC.PP.010August 12, 2016
        Endometrial Ablation (PDF)CP.MP.106November 1, 2024
        Evoked Potential Testing (PDF)CP.MP.134November 1, 2024
        Global Maternity Billing (PDF)CC.PP.016October 18, 2016
        Helicobacter Pylori Serology Testing (PDF)CP.MP.153November 1, 2024
        Holter Monitors (PDF)CP.MP.113June 1, 2024
        Homocysteine Testing (PDF)CP.MP.121May 1, 2023
        Hospital Visit Codes Billed with Labs (PDF)CC.PP.023October 18, 2016
        Inpatient Consultation (PDF)CC.PP.038February 7, 2017
        Inpatient Only Procedures (PDF)MP.PP.018October 18, 2016
        IV Hydration (PDF)CC.PP.012October 18, 2016
        Laser Therapy for Skin Conditions (PDF)CP.MP.123November 1, 2024
        Leveling of Care: Evaluation and Management Overcoding (PDF)CC.PP.066March 15, 2021
        Leveling of Emergency Room (PDF)CC.PP.053 January 1, 2019
        Low-Frequency Ultrasound and Noncontact Normothermic Wound Therapy (PDF)CP.MP.139November 1, 2024
        Maximum Units (PDF)CC.PP.007August 12, 2016
        Measurement of Serum 1,25-dihydroxyvitamin D (PDF)CP.MP.152November 1, 2024
        Moderate Conscious Sedation (PDF)CC.PP.015October 18, 2016
        Modifier -25 Clinical Validation (PDF)CC.PP.013October 18, 2016
        Modifier -59 Clinical Validation (PDF)CC.PP.014October 18, 2016
        Modifier DOS Validation (PDF)CC.PP.034October 18, 2016
        Modifier to Procedure Code Validation (PDF)CC.PP.028October 18, 2016
        Multiple CPT Code Replacement (PDF)CC.PP.033October 18, 2016
        Multiple Diagnostic Cardiovascular Procedure Payment Reduction (PDF)CC.PP.065March 15, 2021
        Multiple Procedure Reduction: Ophthalmology (PDF)CC.PP.069March 15, 2021
        Multiple Procedure Payment Reduction for Therapeutic Services (PDF)CC.PP.068March 15, 2021
        NCCI Unbundling (PDF)CC.PP.031October 18, 2016
        Never Paid Events (PDF)CC.PP.017October 18, 2016
        New Patient (PDF)CC.PP.036February 7, 2017
        Non-Obstetrical Pelvic and Transabdominal Ultrasound (PDF)CC.PP.061 March 15, 2021
        Outpatient Consultation (PDF)CC.PP.039February 7, 2017
        Paclitaxel (PDF)CP.PHAR.176July 1, 2023
        Physician’s Consultation Services (PDF)CC.PP.054September 1, 2018
        Physician Visit Codes Billed with Labs (PDF)CC.PP.019October 18, 2016
        Place of Service Mismatch (PDF)CC.PP.063 December 15, 2018
        Polymerase Chain Reaction Respiratory Viral Panel Testing (PDF)CP.MP.181November 1, 2024
        Post-Operative Visits (PDF)CC.PP.042February 7, 2017
        Pre-Operative Visits (PDF)CC.PP.041February 7, 2017
        Problem Oriented Visits with Surgical Procedures (PDF)CC.PP.052November 1, 2018
        Professional Component (PDF)CC.PP.027October 18, 2016
        Pulmonary Function Testing (PDF)CP.MP.242December 1, 2024
        Pulse Oximetry (PDF)CC.PP.025October 18, 2016
        Renal Hemodialysis (PDF)CC.PP.067March 15, 2021
        Robotic Surgery (PDF)CC.PP.050November 1, 2017
        Same Day Visits (PDF)CC.PP.040February 7, 2017
        Sepsis Diagnosis (PDF)CC.PP.073November 1, 2024
        Severe Malnutrition (PDF)CC.PP.145November 1, 2024
        Skilled Nursing Facility Leveling (PDF)CC.PP.206October 1, 2024
        Status "B" Bundled Services (PDF)CC.PP.046February 7, 2017
        Status "P" Bundled Services (PDF)CC.PP.049June 17, 2017
        Supplies Billed on Same Day As Surgery (PDF)CC.PP.032October 18, 2016
        Supportive Living (PDF)ARTC.PP.1000July 20, 2020
        Testing for Select Genitourinary Conditions (PDF)CP.MP.97June 1, 2024
        Thyroid Hormones and Insulin Testing in Pediatrics (PDF)CP.MP.154November 1, 2024
        Transgender Related Services (PDF)CC.PP.047February 22, 2017
        Ultrasound in Pregnancy (PDF)CP.MP.38June 1, 2024
        Unbundled Professional Services (PDF)CC.PP.043April 6, 2017
        Unbundled Surgical Procedures (PDF)CC.PP.045April 6, 2017
        Unlisted Procedure Codes (PDF)CC.PP.009August 12, 2016
        Urine Specimen Validity Testing (PDF)CC.PP.056November 8, 2017
        Urodynamic Testing (PDF)CP.MP.98November 1, 2024
        Velmanase Alfa-tycv (Lamzede) (PDF)CP.PHAR.601June 1, 2023
        Wheelchair Accessories (PDF)CC.PP.502August 12, 2016
        Wheelchair Seating (PDF)CP.MP.99November 1, 2024
        Wireless Motility Capsule (PDF)CP.MP.143November 1, 2024

        Policy TitlePolicy NumberEffective Date
        Behavioral Health Covered Benefits and Services Addendum F (PDF)CC.BH.UM.28 Addendum FJuly 19, 2022
        Waiver Environmental Modifications Criteria (PDF)ARTC.CC.25September 1, 2022